Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Sobro in connection with the sale of Mercur to Accel-KKR
Mandate

Vinge advises Sobro in connection with the sale of Mercur to Accel-KKR

February 27, 2025 M&A

Vinge has advised Sobro and other shareholders in connection with the sale of Mercur to Accel-KKR’s portfolio company, Aico. Mercur is a leading provider of business management and decision support solutions for medium and large companies and Aico offers an advanced financial closing platform for automation of financial statement processes for medium and large companies.

Vinge’s team primarily consisted of Johan Winnerblad, Per Kling and Alex Forsberg. 

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026